LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $450,000 | -26.4% | 6,190 | +5.6% | 0.04% | +28.6% |
| Q4 2019 | $611,000 | +11.7% | 5,860 | +6.6% | 0.04% | +34.6% |
| Q3 2019 | $547,000 | -48.6% | 5,495 | -41.1% | 0.03% | -44.7% |
| Q2 2019 | $1,065,000 | -70.4% | 9,330 | -67.4% | 0.05% | -66.2% |
| Q1 2019 | $3,597,000 | +3.4% | 28,615 | +11.6% | 0.14% | -0.7% |
| Q4 2018 | $3,480,000 | -47.2% | 25,645 | +6.8% | 0.14% | -27.8% |
| Q3 2018 | $6,593,000 | +91.7% | 24,020 | +44.7% | 0.19% | +84.8% |
| Q2 2018 | $3,439,000 | +35.1% | 16,600 | +7.7% | 0.10% | +29.6% |
| Q1 2018 | $2,545,000 | – | 15,410 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |